BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34103026)

  • 1. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
    Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
    BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
    Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
    Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
    Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
    Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
    Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
    Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
    Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
    Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
    Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
    Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of Autoantibody in Patients with Ischemic Stroke.
    Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
    Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
    Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
    BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
    Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
    Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
    Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
    Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.
    Shiga Y; Kuriyama M; Kanaya Y; Takeshima S; Takemaru M; Takamatsu K; Shimoe Y; Fujikawa Y; Nishigaki M
    Cerebrovasc Dis; 2017; 44(5-6):325-329. PubMed ID: 29073616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Serum Ninjurin-1 Is Associated with a High Risk of Large Artery Atherosclerotic Acute Ischemic Stroke.
    Dong N; Wu X; Hong T; Shen X; Guo X; Wang H; Yu L; Zhao H; Fang Q
    Transl Stroke Res; 2023 Aug; 14(4):465-471. PubMed ID: 36205878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can high uric acid levels be an independent risk factor for acute ischemic stroke due to large-artery atherosclerosis?
    Acar T; Güzey Aras Y; Gül SS; Acar AB
    Ideggyogy Sz; 2018 Jul; 71(7-08):279-283. PubMed ID: 30113796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.
    Yoshida Y; Wang H; Hiwasa T; Machida T; Kobayashi E; Mine S; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Kamitsukasa I; Shin H; Wada T; Aotsuka A; Nishi E; Ohno M; Takemoto M; Yokote K; Takahashi S; Matsushima J; Zhang XM; Takiguchi M; Iwadate Y
    Oncotarget; 2018 Feb; 9(10):8836-8848. PubMed ID: 29507658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Serum Exosomal miR-152-3p Contributes to the Progression of Acute Ischemic Stroke.
    Song P; Sun H; Chen H; Wang Y; Zhang Q
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions.
    Xiao J; Padrick MM; Jiang T; Xia S; Wu F; Guo Y; Gonzalez NR; Li S; Schlick KH; Dumitrascu OM; Maya MM; Diniz MA; Song SS; Lyden PD; Li D; Yang Q; Fan Z
    Atherosclerosis; 2021 Feb; 319():72-78. PubMed ID: 33486353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
    Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bilirubin levels are associated with poor functional outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Ouyang Q; Wang A; Tian X; Zuo Y; Liu Z; Xu Q; Meng X; Chen P; Li H; Wang Y
    BMC Neurol; 2021 Sep; 21(1):373. PubMed ID: 34610800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain in patients with acute cerebrovascular events.
    De Marchis GM; Katan M; Barro C; Fladt J; Traenka C; Seiffge DJ; Hert L; Gensicke H; Disanto G; Sutter R; Peters N; Sarikaya H; Goeggel-Simonetti B; El-Koussy M; Engelter S; Lyrer PA; Christ-Crain M; Arnold M; Kuhle J; Bonati LH
    Eur J Neurol; 2018 Mar; 25(3):562-568. PubMed ID: 29281157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.